These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9393569)

  • 1. Expression of p53 in recurrent nodal metastasis from nasopharyngeal carcinoma (NPC).
    Chow LW; Khoo US; Yuen AP; Wei WI
    Eur J Surg Oncol; 1997 Oct; 23(5):415-8. PubMed ID: 9393569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 overexpression in nasopharyngeal carcinoma.
    Agaoglu FY; Dizdar Y; Dogan O; Alatli C; Ayan I; Savci N; Tas S; Dalay N; Altun M
    In Vivo; 2004; 18(5):555-60. PubMed ID: 15523893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The expression of nm23-H1 and p53 protein in nasopharyngeal carcinoma].
    Zhou Y; Xu A; Ling X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 12(6):243-6. PubMed ID: 11189166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis.
    Zheng Z; Pan J; Chu B; Wong YC; Cheung AL; Tsao SW
    Hum Pathol; 1999 Apr; 30(4):458-66. PubMed ID: 10208469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 and proliferating cell nuclear antigen (PCNA) expression correlates with subsequent local recurrence in nasopharyngeal carcinomas.
    Tsai ST; Jin YT; Leung HW; Wang ST; Tsao CJ; Su IJ
    Anticancer Res; 1998; 18(4B):2849-54. PubMed ID: 9713473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on expression and relationship between proliferating cell nuclear antigen and p53 oncoprotein in nasopharyngeal carcinoma].
    Cheng Q; Wei J; Huang X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(14):643-5. PubMed ID: 16248462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of bcl-2 expression in normal, inflamed, dysplastic nasopharyngeal epithelia, and nasopharyngeal carcinoma: association with p53 expression.
    Sheu LF; Chen A; Meng CL; Ho KC; Lin FG; Lee WH
    Hum Pathol; 1997 May; 28(5):556-62. PubMed ID: 9158704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
    Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
    Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The expression of suppressor gene p16, p21 and p53 in nasopharyngeal carcinoma].
    Lei X; Zhou Y; He X; Chen F
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Sep; 13(9):406-8. PubMed ID: 12541388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between VEGF-C expression and nasopharyngeal carcinoma proliferation and metastasis].
    Shi XY; Hu GQ; Yuan XL; Li HY; Liu YQ; Ma D
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):364-7. PubMed ID: 17045002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53 protein and tumor angiogenesis as prognostic factors in nasopharyngeal carcinoma patients.
    Rubio L; Burgos JS; Lopez-Guerrero JA; Morera C; Vera-Sempere FJ
    Pathol Res Pract; 2002; 198(2):97-102. PubMed ID: 11928871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of recurrent nodal disease after definitive radiation therapy for nasopharyngeal carcinoma: diagnostic value of fine-needle aspiration cytology and CT scan.
    Toh ST; Yuen HW; Goh YH; Goh CH
    Head Neck; 2007 Apr; 29(4):370-7. PubMed ID: 17123306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.
    Ou X; Miao Y; Wang X; Ding J; He X; Hu C
    Radiat Oncol; 2017 Aug; 12(1):137. PubMed ID: 28821277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of nuclear Snail, but not cytoplasmic staining, predicts poor survival in nasopharyngeal carcinoma.
    Luo WR; Li SY; Cai LM; Yao KT
    Ann Surg Oncol; 2012 Sep; 19(9):2971-9. PubMed ID: 22476819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and cervical lymph node metastasis of nasopharyngeal carcinoma.
    Huang T; Chen MH; Wu MY; Wu XY
    Ann Otol Rhinol Laryngol; 2013 Mar; 122(3):210-5. PubMed ID: 23577575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage II recurrent nasopharyngeal carcinoma: Prognostic significance of retropharyngeal nodal metastasis, parapharyngeal invasion, and carotid encasement.
    Chan JYW; Wong STS; Wei WI
    Head Neck; 2018 Jan; 40(1):103-110. PubMed ID: 29083514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of CDK5 infers poor outcomes for nasopharyngeal carcinoma patients.
    Zhang X; Zhong T; Dang Y; Li Z; Li P; Chen G
    Int J Clin Exp Pathol; 2015; 8(7):8066-74. PubMed ID: 26339373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas.
    Chow E; Payne D; Keane T; Panzarella T; Izard MA
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):149-54. PubMed ID: 9300749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of integrin αv in the human nasopharyngeal carcinoma associated with metastasis and progression.
    Xuan SH; Zhou YG; Pan JQ; Zhu W; Xu P
    Cancer Biomark; 2013; 13(5):323-8. PubMed ID: 24440971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.